Stock listing
PCRX Stock Price, News, Filings & Events — Pacira Biosciences, Inc.
Selected listing: PCRX · NASDAQ · USD · US
This page tracks Pacira Biosciences, Inc.'s PCRX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PCRX:NASDAQ. PCRX:NASDAQ is the stock-level entry point for investors researching Pacira Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pacira Biosciences, Inc. is a public company traded under the ticker PCRX in the American market. The company has a market capitalization of approximately $1.01 billion. Pacira focuses on developing and commercializing innovative non-opioid pain management solutions.
- Ticker
- PCRX:NASDAQ
- Asset type
- Stock
- Market cap
- $983.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Pacira Biosciences, Inc. PCRX:NASDAQ stock context
This page tracks Pacira Biosciences, Inc.'s PCRX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PCRX:NASDAQ. PCRX:NASDAQ is the stock-level entry point for investors researching Pacira Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pacira Biosciences, Inc. is a public company traded under the ticker PCRX in the American market. The company has a market capitalization of approximately $1.01 billion. Pacira focuses on developing and commercializing innovative non-opioid pain management solutions.
Latest news from Pacira Biosciences, Inc.
Pacira BioSciences Reports Second Quarter 2026 Financial Results
August 4, 2026
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
July 28, 2026
Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
July 27, 2026
Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026
July 22, 2026
Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet
June 30, 2026
Pacira Biosciences, Inc. earnings calls
Pacira BioSciences, Inc. (PCRX) Q2 2026 Earnings Call
August 4, 2026 · Replay with transcript and chapters
Pacira BioSciences, Inc. (PCRX) Q1 2026 Earnings Call
April 30, 2026 · Replay with transcript and chapters
Pacira BioSciences, Inc. (PCRX) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Pacira BioSciences, Inc. (PCRX) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Pacira BioSciences, Inc. (PCRX) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Pacira BioSciences, Inc. (PCRX) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Pacira Biosciences, Inc.
Pacira Biosciences, Inc. investor report
Review AI stock analysis and investor report context for PCRX:NASDAQ.
Pacira Biosciences, Inc. company profile
View the public company page for Pacira Biosciences, Inc. on 6ix.
Pacira Biosciences, Inc. news
Read company news and market updates connected to Pacira Biosciences, Inc..
Pacira Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Pacira Biosciences, Inc..
Alternate listings
A1H68T:LS
DE · EUR
Alternate listing for Pacira Biosciences, Inc.; the primary context on this page is PCRX:NASDAQ.
82P:FWB
DE · EUR
Alternate listing for Pacira Biosciences, Inc.; the primary context on this page is PCRX:NASDAQ.
A1H68T:LSX
DE · EUR
Alternate listing for Pacira Biosciences, Inc.; the primary context on this page is PCRX:NASDAQ.
82P:GETTEX
DE · EUR
Alternate listing for Pacira Biosciences, Inc.; the primary context on this page is PCRX:NASDAQ.
PCRX:BOATS
US · USD
Alternate listing for Pacira Biosciences, Inc.; the primary context on this page is PCRX:NASDAQ.
82P:MUN
DE · EUR
Alternate listing for Pacira Biosciences, Inc.; the primary context on this page is PCRX:NASDAQ.
82P:TRADEGATE
DE · EUR
Alternate listing for Pacira Biosciences, Inc.; the primary context on this page is PCRX:NASDAQ.
82P:BX
CH · CHF
Alternate listing for Pacira Biosciences, Inc.; the primary context on this page is PCRX:NASDAQ.
82P:DUS
DE · EUR
Alternate listing for Pacira Biosciences, Inc.; the primary context on this page is PCRX:NASDAQ.
82P:SWB
DE · EUR
Alternate listing for Pacira Biosciences, Inc.; the primary context on this page is PCRX:NASDAQ.